Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- Surgeon To Discuss Breast Cancer on KARK-TV
Klimberg on TV/7 will discuss breast cancer diagnosis, treatment, and research
- Surgeon To Discuss Breast Cancer on KARK-TV
Klimberg on TV/7 will discuss breast cancer diagnosis, treatment, and research
- Surgeon To Discuss Breast Cancer on KARK-TV
Klimberg on TV/7 will discuss breast cancer diagnosis, treatment, and research
- Join UAMS Team in Race for the Cure
Sign Up for "Race for the Cure" - deadline is August 22, 2001
- Join UAMS Team in Race for the Cure
Sign Up for "Race for the Cure" - deadline is August 22, 2001
- Join UAMS Team in Race for the Cure
Sign Up for "Race for the Cure" - deadline is August 22, 2001
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
- Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
- Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
- Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
- Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
Start Holiday Shopping Early with an ACRC Auxiliary Partners Card
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- Arkansas Cancer Research Center Foundation Hires New Community Affairs Coordinator, Elects Executive Committee
Arkansas Cancer Research Center Foundation Hires New Community Affairs Coordinator, Elects Executive Committee
- Arkansas Cancer Research Center Foundation Hires New Community Affairs Coordinator, Elects Executive Committee
Arkansas Cancer Research Center Foundation Hires New Community Affairs Coordinator, Elects Executive Committee
- Arkansas Cancer Research Center Foundation Hires New Community Affairs Coordinator, Elects Executive Committee
Arkansas Cancer Research Center Foundation Hires New Community Affairs Coordinator, Elects Executive Committee
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Landmark Breast Cancer Pilot Study at UAMS Examines New Breast Conservation Therapy
LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS), and RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that the first patient in a planned series of 30 received a radiofrequency ablation-assisted lumpectomy procedure.
- Landmark Breast Cancer Pilot Study at UAMS Examines New Breast Conservation Therapy
LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS), and RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that the first patient in a planned series of 30 received a radiofrequency ablation-assisted lumpectomy procedure.
- Landmark Breast Cancer Pilot Study at UAMS Examines New Breast Conservation Therapy
LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS), and RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that the first patient in a planned series of 30 received a radiofrequency ablation-assisted lumpectomy procedure.
- Botox Reduces Pain After Mastectomy, UAMS Study Finds
LITTLE ROCK – Botox, known for reducing wrinkles, also can be used to reduce pain and spasms during breast reconstruction after mastectomy, according to results of a recent University of Arkansas for Medical Sciences (UAMS) study.
- Botox Reduces Pain After Mastectomy, UAMS Study Finds
LITTLE ROCK – Botox, known for reducing wrinkles, also can be used to reduce pain and spasms during breast reconstruction after mastectomy, according to results of a recent University of Arkansas for Medical Sciences (UAMS) study.
- Botox Reduces Pain After Mastectomy, UAMS Study Finds
LITTLE ROCK – Botox, known for reducing wrinkles, also can be used to reduce pain and spasms during breast reconstruction after mastectomy, according to results of a recent University of Arkansas for Medical Sciences (UAMS) study.
- UAMS Continues Cancer Education with Electric Cooperatives Grant
JAN. 04, 2005 | Increased access to cancer screenings and wider distribution of cancer education resources throughout Arkansas is being funded by a $20,000 installment of a $100,000 grant to the University of Arkansas for Medical Sciences (UAMS) from the Electric Cooperatives of Arkansas aimed at reducing cancer in the state.
- UAMS Continues Cancer Education with Electric Cooperatives Grant
JAN. 04, 2005 | Increased access to cancer screenings and wider distribution of cancer education resources throughout Arkansas is being funded by a $20,000 installment of a $100,000 grant to the University of Arkansas for Medical Sciences (UAMS) from the Electric Cooperatives of Arkansas aimed at reducing cancer in the state.
- UAMS Continues Cancer Education with Electric Cooperatives Grant
JAN. 04, 2005 | Increased access to cancer screenings and wider distribution of cancer education resources throughout Arkansas is being funded by a $20,000 installment of a $100,000 grant to the University of Arkansas for Medical Sciences (UAMS) from the Electric Cooperatives of Arkansas aimed at reducing cancer in the state.
- UAMS Continues Cancer Education with Electric Cooperatives Grant
JAN. 04, 2005 | Increased access to cancer screenings and wider distribution of cancer education resources throughout Arkansas is being funded by a $20,000 installment of a $100,000 grant to the University of Arkansas for Medical Sciences (UAMS) from the Electric Cooperatives of Arkansas aimed at reducing cancer in the state.
- UAMS Continues Cancer Education with Electric Cooperatives Grant
JAN. 04, 2005 | Increased access to cancer screenings and wider distribution of cancer education resources throughout Arkansas is being funded by a $20,000 installment of a $100,000 grant to the University of Arkansas for Medical Sciences (UAMS) from the Electric Cooperatives of Arkansas aimed at reducing cancer in the state.
- UAMS Family Home gets Holiday Boost with $130,000 in Donations from ACRC Auxiliary and Tiny Hands Monster Bash
JAN. 7, 2005 | An unexpected Christmas gift left supporters of the University of Arkansas for Medical Sciences (UAMS) Family Home astonished recently as gifts from the Arkansas Cancer Research Center (ACRC) Auxiliary and the Tiny Hands Monster Bash raised $130,000 for the facility.
- UAMS Family Home gets Holiday Boost with $130,000 in Donations from ACRC Auxiliary and Tiny Hands Monster Bash
JAN. 7, 2005 | An unexpected Christmas gift left supporters of the University of Arkansas for Medical Sciences (UAMS) Family Home astonished recently as gifts from the Arkansas Cancer Research Center (ACRC) Auxiliary and the Tiny Hands Monster Bash raised $130,000 for the facility.
- UAMS Family Home gets Holiday Boost with $130,000 in Donations from ACRC Auxiliary and Tiny Hands Monster Bash
JAN. 7, 2005 | An unexpected Christmas gift left supporters of the University of Arkansas for Medical Sciences (UAMS) Family Home astonished recently as gifts from the Arkansas Cancer Research Center (ACRC) Auxiliary and the Tiny Hands Monster Bash raised $130,000 for the facility.
- UAMS Family Home gets Holiday Boost with $130,000 in Donations from ACRC Auxiliary and Tiny Hands Monster Bash
JAN. 7, 2005 | An unexpected Christmas gift left supporters of the University of Arkansas for Medical Sciences (UAMS) Family Home astonished recently as gifts from the Arkansas Cancer Research Center (ACRC) Auxiliary and the Tiny Hands Monster Bash raised $130,000 for the facility.
- ACRC Receives Generous Donation from Affiliated Foods
JAN. 26 2005 | Affiliated Foods recently gave a generous donation of $25,000 to the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS) from funds raised during their Team Affiliated Charity Classic.
- ACRC Receives Generous Donation from Affiliated Foods
JAN. 26 2005 | Affiliated Foods recently gave a generous donation of $25,000 to the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS) from funds raised during their Team Affiliated Charity Classic.
- ACRC Receives Generous Donation from Affiliated Foods
JAN. 26 2005 | Affiliated Foods recently gave a generous donation of $25,000 to the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS) from funds raised during their Team Affiliated Charity Classic.
- ACRC Receives Generous Donation from Affiliated Foods
JAN. 26 2005 | Affiliated Foods recently gave a generous donation of $25,000 to the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS) from funds raised during their Team Affiliated Charity Classic.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Myeloma Patient's Fundraiser Raises Eyebrows, Spirits
FEB. 22, 2005 | Friends and family of Camille Fuller aren’t afraid to display their affection for her. Or anything else, for that matter.
- UAMS Myeloma Patient's Fundraiser Raises Eyebrows, Spirits
FEB. 22, 2005 | Friends and family of Camille Fuller aren’t afraid to display their affection for her. Or anything else, for that matter.
- UAMS Myeloma Patient's Fundraiser Raises Eyebrows, Spirits
FEB. 22, 2005 | Friends and family of Camille Fuller aren’t afraid to display their affection for her. Or anything else, for that matter.
- UAMS Myeloma Patient's Fundraiser Raises Eyebrows, Spirits
FEB. 22, 2005 | Friends and family of Camille Fuller aren’t afraid to display their affection for her. Or anything else, for that matter.
- Free or Low-Cost Health Screenings for Women Offered March 16 in Arkansas County
LITTLE ROCK – Free or low-cost breast exams, pap tests and mammograms are available to Arkansas County women 40 and older who qualify through The Witness Project, a community-based cancer education program of the University of Arkansas for Medical Sciences (UAMS) College of Public Health and the Arkansas Cancer Research Center (ACRC).
- Free or Low-Cost Health Screenings for Women Offered March 16 in Arkansas County
LITTLE ROCK – Free or low-cost breast exams, pap tests and mammograms are available to Arkansas County women 40 and older who qualify through The Witness Project, a community-based cancer education program of the University of Arkansas for Medical Sciences (UAMS) College of Public Health and the Arkansas Cancer Research Center (ACRC).
- Free or Low-Cost Health Screenings for Women Offered March 16 in Arkansas County
LITTLE ROCK – Free or low-cost breast exams, pap tests and mammograms are available to Arkansas County women 40 and older who qualify through The Witness Project, a community-based cancer education program of the University of Arkansas for Medical Sciences (UAMS) College of Public Health and the Arkansas Cancer Research Center (ACRC).
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
OCT. 20, 2004 | Custom-made omelets and birthday cake marked a week of festivities for patients, families and employees Oct. 11-15 as they celebrated the 15th anniversary of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS).
Founded in 1984, the ACRC is the primary cancer research institution in Arkansas and has become one of the top cancer centers in the United States. Today, it is a leader in the fight against cancer through research, education, prevention, outreach and patient care.
To mark the facility’s 15th year, the focus was placed on the patients, who entrust their diagnosis and treatment to the ACRC; and the employees, whose personal commitment is vital to allowing the ACRC to deliver its cutting-edge services. Both groups were recognized with activities through the week.
Twice during the week, large cakes were wheeled into the clinic areas and volunteers served cake and fruit punch to patients and families who were at the ACRC for tests or treatment.
“We form strong bonds with our patients because they come to our center for extended care – some are here for hours each week,” said Shirley Gray, ACRC director of administration. “Naturally we wanted to celebrate this anniversary with them and show our appreciation for entrusting us with their care.”
Then on Friday, The Egg Council of the Arkansas Livestock and Poultry Commission helped host a breakfast honoring cancer center employees. James Y. Suen, M.D., ACRC director; Kent Westbrook, M.D., founding director, and other ACRC administrators, cooked up made to order omelets for more than 350 ACRC employees.
“The Arkansas Cancer Research Center will always be dedicated to innovative research and state-of-the-art treatment, but our patients have been and always will be our primary concern,” Suen said. “We are pleased on this 15th anniversary to honor both our employees – who are the ones that make this place go – as well as our patients, who serve as constant reminders of our mission to search for a cure.”
Links on This Page
The Arkansas Cancer Research Center: http://www.acrc.uams.edu/
|